Inflammatory profiling of patients with familial amyloid polyneuropathy
- PMID: 31253122
- PMCID: PMC6599258
- DOI: 10.1186/s12883-019-1369-4
Inflammatory profiling of patients with familial amyloid polyneuropathy
Abstract
Background: Familial amyloid polyneuropathy (FAP) or ATTRv (amyloid TTR variant) amyloidosis is a fatal hereditary disease characterized by the deposition of amyloid fibrils composed of transthyretin (TTR). The current diagnosis of ATTRv relies on genetic identification of TTR mutations and on Congo Red-positive amyloid deposits, which are absent in most ATTRv patients that are asymptomatic or early symptomatic, supporting the need for novel biomarkers to identify patients in earlier disease phases allowing disease control.
Methods: In an effort to search for new markers for ATTRv, our group searched for nine inflammation markers in ATTRv serum from a cohort of 28 Brazilian ATTRv patients.
Results: We found that the levels of six markers were increased (TNF-α, IL-1β, IL-8, IL-33, IFN-β and IL-10), one had decreased levels (IL-12) and two of them were unchanged (IL-6 and cortisol). Interestingly, asymptomatic patients already presented high levels of IL-33, IL-1β and IL-10, suggesting that inflammation may take place before fibril deposition.
Conclusions: Our findings shed light on a new, previously unidentified aspect of ATTRv, which might help define new criteria for disease management, as well as provide additional understanding of ATTRv aggressiveness.
Keywords: Amyloid; Biomarkers; Cytokines; Familial amyloid polyneuropathy; Transthyretin.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis.Cells. 2023 Sep 29;12(19):2383. doi: 10.3390/cells12192383. Cells. 2023. PMID: 37830598 Free PMC article. Review.
-
Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.Eur J Neurol. 2022 May;29(5):1477-1487. doi: 10.1111/ene.15268. Epub 2022 Feb 18. Eur J Neurol. 2022. PMID: 35100482
-
Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures.Theranostics. 2016 Jul 18;6(11):1792-809. doi: 10.7150/thno.14584. eCollection 2016. Theranostics. 2016. PMID: 27570551 Free PMC article.
-
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.Amyloid. 2021 Mar;28(1):50-55. doi: 10.1080/13506129.2020.1815696. Epub 2020 Sep 4. Amyloid. 2021. PMID: 32883119
-
Hereditary transthyretin amyloidosis: current treatment.Curr Opin Neurol. 2020 Oct;33(5):553-561. doi: 10.1097/WCO.0000000000000852. Curr Opin Neurol. 2020. PMID: 32796279 Review.
Cited by
-
Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis.Ann Clin Transl Neurol. 2024 Jan;11(1):30-44. doi: 10.1002/acn3.51930. Epub 2023 Oct 30. Ann Clin Transl Neurol. 2024. PMID: 37902278 Free PMC article.
-
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis.Cells. 2023 Sep 29;12(19):2383. doi: 10.3390/cells12192383. Cells. 2023. PMID: 37830598 Free PMC article. Review.
-
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal.Orphanet J Rare Dis. 2023 Oct 12;18(1):323. doi: 10.1186/s13023-023-02910-3. Orphanet J Rare Dis. 2023. PMID: 37828588 Free PMC article. Review.
-
Inflammation across the spectrum of hypertrophic cardiac phenotypes.Heart Fail Rev. 2023 Sep;28(5):1065-1075. doi: 10.1007/s10741-023-10307-4. Epub 2023 Apr 28. Heart Fail Rev. 2023. PMID: 37115472 Free PMC article. Review.
-
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.J Neurol. 2023 Jul;270(7):3483-3491. doi: 10.1007/s00415-023-11689-z. Epub 2023 Apr 4. J Neurol. 2023. PMID: 37014422 Free PMC article.
References
-
- Coelho T, Carvalho M, Saraiva MJ, Alves I, Almeida MR, Costa PP. A strikingly benign evolution of ATTRV in an individual found to be a compound heterozygote for two TTR mutations: TTR MET 30 and TTR MET 119. J Rheumatol. 1993;20:179.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
